Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

NCT00506168 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

37

Enrollment

OTHER_GOV

Sponsor class

Stopped The study drugs are not covered anymore by insurance.

Conditions

Colorectal Neoplasms
Secondary
Drug Therapy, Combination

Interventions

DRUG: Irinotecan, Capecitabine

Sponsor

National Cancer Center, Korea